Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Head and Neck Cancer

Free Subscription 06.07.2026 1 Am J Gastroenterol 8 Anticancer Res 25 BMC Cancer 13 BMC Surg 2 Br J Cancer 3 Clin Cancer Res 3 Dis Esophagus 6 Head Neck 1 Int J Radiat Oncol Biol Phys 1 J Clin Endocrinol Metab 1 J Laryngol Otol 3 J Oral Maxillofac Surg 3 Ophthalmic Plast Reconstr Surg 4 Oral Oncol 7 Otolaryngol Head Neck Surg 6 Radiother Oncol 1 Surgery 6 Thyroid

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Gastroenterol

1. BIAN Y, Xu Y, Chu C, Gao Y, et al
   Accurate Nonendoscopic Detection of Early Esophageal Squamous Malignant Lesions Using Sponge-Based Methylated DNA Biomarkers.
   Am J Gastroenterol. 2026;121:1600-1608.
   PubMed         Abstract available
   
   

   
   Anticancer Res

2. HAMAI Y, Ibuki Y, Ohsawa M, Kitasaki N, et al
   Comparison of Short-term Outcomes Between Thoracoscopic and Robot-assisted Minimally Invasive Esophagectomy for Esophageal Cancer: A Propensity Score-matched Analysis.
   Anticancer Res. 2026;46:3939-3953.
   PubMed         Abstract available
   
   
3. UTSUMI N, Kawamura H, Yamano T, Hayakawa T, et al
   Clinical Value of Pre-treatment Immunonutritional Indices in T4 Esophageal Cancer Treated With Radiotherapy.
   Anticancer Res. 2026;46:3879-3887.
   PubMed         Abstract available
   
   
4. WANG MH, Pan MR, Hung YH
   Ubiquitin-specific Peptidase 53 Suppresses Head/Neck Tumorigenesis by Stabilizing FBXW7.
   Anticancer Res. 2026;46:3771-3781.
   PubMed         Abstract available
   
   
5. HOSHINO N, Yoshida K, Kanemitsu Y, Toyama A, et al
   Association Between Individualized Estimated Glomerular Filtration Rate and Cumulative Cisplatin Dose in Head and Neck Cancer.
   Anticancer Res. 2026;46:4055-4065.
   PubMed         Abstract available
   
   
6. KAWAKAMI O, Shimasaki M, Shimode Y, Kumagai M, et al
   Microvessel Maturation Correlates With Doppler Ultrasound Indices and Vascular Invasion in Follicular Thyroid Tumors.
   Anticancer Res. 2026;46:4067-4076.
   PubMed         Abstract available
   
   
7. HOUR TC, Huang CH, Chang HW, Chuu CP, et al
   Epigallocatechin Gallate Attenuates Arecoline-induced Migration and Invasion in Esophageal Squamous Cell Carcinoma Cells Associated With EGFR/AKT/P38 Signaling.
   Anticancer Res. 2026;46:3815-3829.
   PubMed         Abstract available
   
   
8. HIRATA A, Hayano K, Hanaoka T, Kurata Y, et al
   Prognostic Significance of FDG Uptake in Metastatic Lymph Nodes of Esophageal Squamous Cell Carcinoma.
   Anticancer Res. 2026;46:4099-4106.
   PubMed         Abstract available
   
   
9. MATOBA T, Kawakita D, Minohara K, Iwaki S, et al
   Neoadjuvant Chemotherapy With Paclitaxel, Carboplatin, and Cetuximab for Locally Advanced Head and Neck Cancer.
   Anticancer Res. 2026;46:4031-4043.
   PubMed         Abstract available
   
   

   
   BMC Cancer

10. HAN Y, Wang Q, Chen Y, Wu H, et al
    Platinum-free triplet therapy with nab-paclitaxel, S-1, and tislelizumab as first-line treatment for advanced gastric/gastroesophageal junction adenocarcinoma: a phase ii single-arm trial.
    BMC Cancer. 2026;26:546.
    PubMed         Abstract available
    
    
11. SENEVIRATHNA K, Francis AH, Pirzada M, Mahakapuge TAN, et al
    An exploratory ATR-FTIR spectroscopic study of serum protein structural alterations in oral squamous cell carcinoma and oral potentially malignant disorders.
    BMC Cancer. 2026;26:539.
    PubMed         Abstract available
    
    
12. TAWAKOLI MF, Salihee H, Rahmati A, Hatami MN, et al
    Hospital-based patterns of esophageal and gastric cancer cases at a major tertiary referral center in Kabul, Afghanistan: a retrospective case series.
    BMC Cancer. 2026 Mar 29. doi: 10.1186/s12885-026-15945.
    PubMed        
    
    
13. MIAO J, Cheng W, Ding L, Fu H, et al
    Comparative outcomes of retreatment vs follow-up in DTC patients with intermediate response following initial radioactive iodine therapy: a retrospective cohort study.
    BMC Cancer. 2026;26:594.
    PubMed         Abstract available
    
    
14. CHEN R, Ding Y, Zhao L, Yu Z, et al
    Development and validation of a metabolic-inflammatory-nutritional prognostic model for esophageal squamous carcinoma.
    BMC Cancer. 2026 Apr 15. doi: 10.1186/s12885-026-16007.
    PubMed        
    
    
15. ABDULLAHI IM, Yasin NA, Adani AA, Ali IM, et al
    Correlation between fine needle aspiration cytology with histopathology of non-thyroidal head and neck lesions: first report from Somalia.
    BMC Cancer. 2026 Apr 16. doi: 10.1186/s12885-026-16018.
    PubMed        
    
    
16. QIU X, Cheng L, Jin Y, Fu H, et al
    Disease status stratification individualizes radioiodine therapy for differentiated thyroid cancer: a prospective, multicenter, real-world study.
    BMC Cancer. 2026 Apr 24. doi: 10.1186/s12885-026-16030.
    PubMed        
    
    
17. YI W, Muhetaer K, Chen L, Ma X, et al
    Immunotherapy combined with chemotherapy as first-line treatment for HER2-negative advanced gastric or gastroesophageal junction cancer: systematic review and Bayesian network meta-analysis based on specific PD-L1 expression levels.
    BMC Cancer. 2026;26:780.
    PubMed         Abstract available
    
    
18. ABU HEJLEH A, Lemties J, Kreutzer I, Wirsik NM, et al
    Complications and survival after Ivor Lewis esophagectomy.
    BMC Cancer. 2026;26:802.
    PubMed         Abstract available
    
    
19. WANG L, Mao W, Deng H, Zhou WP, et al
    Diagnostic accuracy in BRAF V600E-negative papillary thyroid cancer via 5-gene expression profiling of residual nucleic acids from mutation testing: a retrospective study.
    BMC Cancer. 2026 Mar 10. doi: 10.1186/s12885-026-15818.
    PubMed        
    
    
20. SMITH G, Boey TY, Chu SY, Chan CMH, et al
    Experiences of swallowing and communication after nasopharyngeal cancer in Malaysian men: a qualitative study.
    BMC Cancer. 2026;26:490.
    PubMed         Abstract available
    
    
21. LIN W, Xiao L, Chen J, Lin X, et al
    Comparison of six-degree-of-freedom registration errors across different anatomical registration regions in head and neck radiotherapy under identical CBCT conditions.
    BMC Cancer. 2026;26:477.
    PubMed         Abstract available
    
    
22. WU H, Yuejiao D, Hong L, Qin J, et al
    IL-23 as a potential mediator of immune evasion and therapeutic target in laryngeal squamous cell carcinoma.
    BMC Cancer. 2026;26:464.
    PubMed         Abstract available
    
    
23. HU S, Wang Q, Wei H, Sun H, et al
    Long non-coding RNA HOXC-AS3 promotes proliferation and metastasis of esophageal squamous carcinoma by targeting WNT3A through binding to YBX1.
    BMC Cancer. 2026;26:381.
    PubMed         Abstract available
    
    
24. OWIBINGIRE SS, Minja IK, Simon EN, Costea DE, et al
    Assessing the covariates of delay in seeking health care among patients with oral and oropharyngeal squamous cell carcinoma in Tanzania.
    BMC Cancer. 2026;26:392.
    PubMed         Abstract available
    
    
25. LAMY C, Laurent L, Choussy O, Pouget N, et al
    SCANDARE: an institutional dynamic prospective interventional biobanking study.
    BMC Cancer. 2026;26:330.
    PubMed         Abstract available
    
    
26. ANBARI F, Heydari SM, Bakhtiari S, Younesi Pour Masouleh S, et al
    Effect of alpha-lipoic acid on salivary secretion in patients undergoing head and neck radiotherapy: a randomized clinical trial.
    BMC Cancer. 2026;26:318.
    PubMed         Abstract available
    
    
27. HUANG D, Guo Y, Chen M, Chen G, et al
    Multi-omics characterization of C4orf19 in HNSCC: constructing prognostic signatures for immunotherapy and chemotherapy response prediction.
    BMC Cancer. 2026;26:309.
    PubMed         Abstract available
    
    
28. LIU L, Zhang X, Zeng C, Hu Y, et al
    Younger women with esophageal carcinoma exhibit improved prognosis after esophagectomy: a single-center, high-volume cohort study.
    BMC Cancer. 2026;26:303.
    PubMed         Abstract available
    
    
29. LUO C, Li J, Mu W, Yuan M, et al
    The value of 3D contrast-enhanced CT radiomics in predicting response to neoadjuvant chemotherapy for adenocarcinoma of the esophagogastric junction: a two-center study.
    BMC Cancer. 2026;26:259.
    PubMed         Abstract available
    
    
30. LIU PT, Chiang CJ, Yang YW, Lee WC, et al
    Prognostic heterogeneity of HPV-associated oropharyngeal cancer in a Taiwanese population.
    BMC Cancer. 2026 Jan 5. doi: 10.1186/s12885-025-15528.
    PubMed         Abstract available
    
    
31. KNIPPER K, Bruns CJ, Popp FC, Schmidt T, et al
    MDM2-amplified esophageal adenocarcinomas exhibit an activated metabolic and immunosuppressive phenotype with multiple potential therapeutic targets.
    BMC Cancer. 2025;25:1863.
    PubMed         Abstract available
    
    
32. HE L, Zeng Y, Gao Y, Xie X, et al
    Network-based integrative transcriptomic analysis reveals immune-regulatory and oncogenic signatures of EOMES and SPRYD3 in head and neck squamous cell carcinoma.
    BMC Cancer. 2026 Jul 1. doi: 10.1186/s12885-026-16379.
    PubMed         Abstract available
    
    
33. HEFZI D, Koopaie M, Hakimiha N, Younespour S, et al
    Nano-silymarin combined with methylene blue photodynamic therapy versus monotherapies of head and neck squamous cell carcinoma: in-vitro study.
    BMC Cancer. 2026 Jun 29. doi: 10.1186/s12885-026-16422.
    PubMed         Abstract available
    
    
34. LIN Z, Song W, Liang W, Liu J, et al
    Potential evaluation of SULT1A3 as an early diagnostic marker for nasopharyngeal carcinoma: a study based on serum proteomics screening and ELISA validation.
    BMC Cancer. 2026 Jun 27. doi: 10.1186/s12885-026-16428.
    PubMed         Abstract available
    
    

    
    BMC Surg

35. WANG Q, Ma H, Li M, Ma Y, et al
    Construction and application of a risk prediction model for sputum viscosity in patients with laryngeal malignant tumors after operation.
    BMC Surg. 2025;25:549.
    PubMed         Abstract available
    
    
36. ZHOU L, Zhang H, Jiang H, Lv X, et al
    Successful prevention of carotid artery rupture by placing a covered stent before salvage resection of advanced recurrent tongue cancer: a case report.
    BMC Surg. 2026;26:138.
    PubMed         Abstract available
    
    
37. AOKI T, Goto H, Koterazawa Y, Ando M, et al
    SPY-QP-guided perfusion assessment to prevent esophagogastric anastomotic leakage: protocol for the SPYMIE study.
    BMC Surg. 2026;26:155.
    PubMed         Abstract available
    
    
38. JI X, Yang X, Jiang Z, Zhao H, et al
    Pedicled versus free flap reconstruction in head and neck surgery: analysis of complications and quality of life.
    BMC Surg. 2026;26:165.
    PubMed         Abstract available
    
    
39. YANG Z, Fan Y, Wei J, Nan L, et al
    Comparison of timing for early postoperative intake in patients with upper gastrointestinal cancer: a network meta-analysis.
    BMC Surg. 2026;26:185.
    PubMed         Abstract available
    
    
40. KARATAS M, Durgut O, Solmaz F, Dikici O, et al
    Impact of skin flap elevation technique on the extent of gustatory sweating after superficial parotidectomy: a comparative study.
    BMC Surg. 2026;26:226.
    PubMed         Abstract available
    
    
41. ONDES B, Gokdere OG
    Impact of the COVID-19 Pandemic on parathyroid adenoma surgery: a single-center comparative experience.
    BMC Surg. 2026;26:240.
    PubMed         Abstract available
    
    
42. LIN R, Zhang J, Weng G, Lin Y, et al
    Preoperative CT three-dimensional reconstruction guides single-incision minimally invasive esophagectomy with retrosternal route selection: a prospective cohort study.
    BMC Surg. 2026;26:272.
    PubMed         Abstract available
    
    
43. LI S, Feng Z, Tang Q, Wang X, et al
    Reinnervated free gracilis flap with basal curtain barrier for tongue reconstruction: a case series and surgical technique.
    BMC Surg. 2026;26:310.
    PubMed         Abstract available
    
    
44. YE Y, Wang X, Liu Y, Qin L, et al
    Different approaches of dissecting the recurrent laryngeal nerve during total thyroidectomy affect postoperative parathyroid function.
    BMC Surg. 2026 Apr 1. doi: 10.1186/s12893-026-03678.
    PubMed        
    
    
45. JIMENEZ HENRIQUEZ RM, Kalandarishvili M, Lummer V, Weitz J, et al
    Anastomotic leakage after esophagogastric resection increases recurrence risk and impairs long-term survival - a propensity score-matched analysis.
    BMC Surg. 2026;26:279.
    PubMed         Abstract available
    
    
46. YUAN X, Zhang X, Jiang Z, Ainiwaer M, et al
    Feasibility and role of the lateral arm free flap following pull-through oropharyngectomy for tonsillar carcinoma: a clinical analysis.
    BMC Surg. 2026;26:378.
    PubMed         Abstract available
    
    
47. FUJITA K, Ogawa R, Hayashi S, Tsuji E, et al
    Expanded use of triclosan-coated sutures for surgical site infection prevention in oesophageal cancer surgery.
    BMC Surg. 2026;26:383.
    PubMed         Abstract available
    
    

    
    Br J Cancer

48. GORDON A, Tran A, Fong C, Cromarty S, et al
    Maintenance capecitabine after first-line platinum-based chemotherapy in advanced oesophagogastric adenocarcinoma: final analysis from the PLATFORM trial.
    Br J Cancer. 2026;135:240-247.
    PubMed         Abstract available
    
    
49. FLANDERS L, Savy T, Ficial M, Al-Ghraibawi N, et al
    PD-L1 CPS in gastroesophageal cancer: differences in routine care versus Checkmate 649 and implications for biopsy-site choice and assay standardisation.
    Br J Cancer. 2026;135:232-239.
    PubMed         Abstract available
    
    

    
    Clin Cancer Res

50. SHI F, Chai W, Yang H, Cao W, et al
    AL2846, a novel multi-kinase inhibitor, for previously treated radioiodine-refractory differentiated thyroid cancer: Exploratory clinical results from the phase Ib study.
    Clin Cancer Res. 2026 Apr 9. doi: 10.1158/1078-0432.CCR-25-3945.
    PubMed         Abstract available
    
    
51. GARRALDA E, Markert C, Moreno V, Calvo E, et al
    A first-in-human phase 1 clinical trial evaluating clinical activity and proof-of-mechanism of tobemstomig, a PD1-LAG3 bispecific antibody, in patients with CPI-experienced melanoma.
    Clin Cancer Res. 2026 Apr 7. doi: 10.1158/1078-0432.CCR-25-4478.
    PubMed         Abstract available
    
    
52. AN PG, Zhang J, Hu X, Zhang ZQ, et al
    Preoperative Chemoimmunotherapy Followed by Salvage Surgery and Adjuvant Tislelizumab for Previously Irradiated Recurrent HNSCC: A Prospective Phase II Trial.
    Clin Cancer Res. 2026;32:2572-2580.
    PubMed         Abstract available
    
    

    
    Dis Esophagus

53. LEONARD D, Thota PN, Sehgal V
    Screening for Barrett's esophagus and esophageal adenocarcinoma: recent advances and next steps.
    Dis Esophagus. 2026;39:doag067.
    PubMed         Abstract available
    
    
54. WU H, Han Z, Wu J, Zhang Y, et al
    CD39 and PD-L1 co-expression may serve as potential indicators for evaluating the efficacy of neoadjuvant immunotherapy in esophageal squamous cell carcinoma.
    Dis Esophagus. 2026;39:doag063.
    PubMed         Abstract available
    
    
55. YANG Y, Fan X, Hong H, Ding J, et al
    Diagnostic performance of postoperative endoscopy versus water-soluble esophagram in detecting anastomotic leak after esophagectomy.
    Dis Esophagus. 2026;39:doag062.
    PubMed         Abstract available
    
    

    
    Head Neck

56. HELOU V, Reddy PD, Rumde PH, Klem ML, et al
    Measurement Tools for Radiation-Induced Fibrosis in Head and Neck Cancer: A Systematic Review.
    Head Neck. 2026 Jul 2. doi: 10.1002/hed.70380.
    PubMed         Abstract available
    
    
57. WANG J, Zhao R, Zhang X, Yuan J, et al
    Neoadjuvant Immunochemotherapy Reduces Major Wound Complications in Oral Cancer Surgery.
    Head Neck. 2026 Jul 1. doi: 10.1002/hed.70375.
    PubMed         Abstract available
    
    
58. SEXTON ETS, Ray HJ, Frowen JJ, Gough K, et al
    Feasibility and Acceptability of a Co-Designed Model of Prehabilitation for Head and Neck Cancer Patients Undergoing Radiotherapy.
    Head Neck. 2026 Jun 30. doi: 10.1002/hed.70351.
    PubMed         Abstract available
    
    
59. BALOGUN Z, Obuekwe F, Bender C, Li J, et al
    Neurocognitive Function in Head and Neck Cancer Patients Prior to Radiation Therapy.
    Head Neck. 2026 Jun 30. doi: 10.1002/hed.70293.
    PubMed         Abstract available
    
    
60. ALDOHAN M, Karam I, Safavi AH, Chin L, et al
    Stereotactic Body Radiotherapy (SBRT) of Previously Unirradiated Mucosal Head and Neck Squamous Cell Carcinoma (SCC).
    Head Neck. 2026 Jun 29. doi: 10.1002/hed.70360.
    PubMed         Abstract available
    
    
61. MA L, Fu F, Wang W, Zhou Y, et al
    Local Consolidative Radiotherapy Combined With Immunochemotherapy for De Novo Metastatic Nasopharyngeal Carcinoma: A Meta-Analysis.
    Head Neck. 2026 Jun 28. doi: 10.1002/hed.70366.
    PubMed         Abstract available
    
    

    
    Int J Radiat Oncol Biol Phys

62. LI W, Li Z, Shi Y, Lam S, et al
    Privacy-Preserving Virtual Contrast-enhanced MRI for Nasopharyngeal Carcinoma: A Multi-center Study.
    Int J Radiat Oncol Biol Phys. 2026 Jul 2:S0360-3016(26)03918.
    PubMed         Abstract available
    
    

    
    J Clin Endocrinol Metab

63. SONG JX, Yang YY, Zhou JX, Xie J, et al
    Parathyroid Carcinoma: From Molecular Pathogenesis to Multidisciplinary Management.
    J Clin Endocrinol Metab. 2026 Jul 4:dgag266. doi: 10.1210.
    PubMed         Abstract available
    
    

    
    J Laryngol Otol

64. IQBAL S, Illahi S, Zaheer R, Iqbal A, et al
    Prognostic value of gross tumour volume in laryngeal cancer: a systematic review and meta-analysis.
    J Laryngol Otol. 2026 Jul 2:1-26. doi: 10.1017/S0022215126105313.
    PubMed        
    
    

    
    J Oral Maxillofac Surg

65. VAN DE SCHOOR CCE, Bittermann GKP, Hagens ERC, Vaassen LAA, et al
    Histopathological Margins and Recurrence Risk in Oral Squamous Cell Carcinoma: Is 3 mm Enough?
    J Oral Maxillofac Surg. 2026;84:1123-1132.
    PubMed         Abstract available
    
    
66. BOEHM A, Workman J, Kookal KK, Ekwaru JP, et al
    Identifying Malignant Transformation Risk of Dysplastic Oral Lesions Using the S100A7 Biomarker Signature-Based Assay.
    J Oral Maxillofac Surg. 2026;84:1133-1142.
    PubMed         Abstract available
    
    
67. DE ALMEIDA LIMA BORBA LOPES A, Marques LC, Madureira Correa YP, Cunha KS, et al
    Factors Associated With Oral Epithelial Dysplasia in Oral Potentially Malignant Disorders.
    J Oral Maxillofac Surg. 2026;84:1105-1112.
    PubMed         Abstract available
    
    

    
    Ophthalmic Plast Reconstr Surg

68. OZGUR SARI AN, Yuksel N, Ozensoy Guler O, Kilic HA, et al
    Evaluation of Carbonic Anhydrase IX and Serum Antioxidant Enzymes in Patients With Periocular Basal Cell Carcinoma.
    Ophthalmic Plast Reconstr Surg. 2026;42:429-435.
    PubMed         Abstract available
    
    
69. SINHA K, Dermarkarian CR
    Persistent Unilateral Scleral Icterus in a Patient with Gilbert Syndrome and Prior Facial Malignancy: A Case Report and Review of the Literature.
    Ophthalmic Plast Reconstr Surg. 2026;42:e186-e188.
    PubMed         Abstract available
    
    
70. VOGT AZ, Dalal S, Modi GM, Vrcek IM, et al
    Utilization of a Sterile Button for Reconstruction of the Medial Canthal Concavity.
    Ophthalmic Plast Reconstr Surg. 2026;42:e161-e164.
    PubMed         Abstract available
    
    

    
    Oral Oncol

71. HAM ND, Ershadifar S, Garber B, Li M, et al
    Patient preferences for mental health care in head and neck cancer: A head and neck cancer Alliance survey.
    Oral Oncol. 2026;180:108074.
    PubMed         Abstract available
    
    
72. GAFFNEY J, France A, Rieu R, Wang Y, et al
    Evaluation of radiotherapy dose and survival outcomes for teenagers, and young adults with nasopharyngeal carcinoma in UK & Ireland.
    Oral Oncol. 2026;180:108062.
    PubMed         Abstract available
    
    
73. TOPKAN E, Somay E, Selek U
    Re: Ensemble learning-based radiomics model for predicting radiation-induced temporal lobe injury in nasopharyngeal carcinoma.
    Oral Oncol. 2026;180:108067.
    PubMed        
    
    
74. OU C, Qi L, Lai H, Ye J, et al
    Mechanisms and clinical challenges of ICB-mediated remodeling of the tumor microenvironment in nasopharyngeal carcinoma.
    Oral Oncol. 2026;180:108017.
    PubMed         Abstract available
    
    

    
    Otolaryngol Head Neck Surg

75. LEVI G, Hamzany Y, Tsur N, Strenov Y, et al
    The Reliability of Intraoperative Frozen Section for Glottic Lesions Suspected of Early Malignancy.
    Otolaryngol Head Neck Surg. 2026;175:173-180.
    PubMed         Abstract available
    
    
76. URALOV D, Pace GM, Canali L, Teriaca A, et al
    Adjuvant Radiotherapy and Local Control After Total Laryngectomy With Preoperative Tracheotomy: A Systematic Review and Meta-Analysis.
    Otolaryngol Head Neck Surg. 2026;175:49-60.
    PubMed         Abstract available
    
    
77. HABIB DRS, Sridhar S, Suh H, Larson D, et al
    Mental Health Risk Factors for Postoperative Pain in Head and Neck Free Flap Reconstruction Patients.
    Otolaryngol Head Neck Surg. 2026;175:86-94.
    PubMed         Abstract available
    
    
78. KOMINSKY E, Ansari M, Moore M, Sim M, et al
    Adjuvant Radiotherapy and Survival in Parotid Gland Adenoid Cystic Carcinoma: A National Cancer Database Analysis.
    Otolaryngol Head Neck Surg. 2026;175:165-172.
    PubMed         Abstract available
    
    
79. SRIDHAR S, Larson DP, Topf MC
    Mucosal Margin Shrinkage in Oral Cavity Cancer: A Systematic Review.
    Otolaryngol Head Neck Surg. 2026;175:31-38.
    PubMed         Abstract available
    
    
80. JACKERT EP, Wong S, Shen K, Zalin M, et al
    Predictors of Recurrence in Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma.
    Otolaryngol Head Neck Surg. 2026;175:126-135.
    PubMed         Abstract available
    
    
81. HUBBARD MG, Lei GS, Emerson R, Schreiber D, et al
    Nanopore Sequencing for HPV in Oropharyngeal Squamous Cell Carcinoma and Benign Tonsil Specimens.
    Otolaryngol Head Neck Surg. 2026;175:136-144.
    PubMed         Abstract available
    
    

    
    Radiother Oncol

82. BELTZUNG F, Biau J, Pereira B, Saroul N, et al
    Tumor immune microenvironment predicts recurrence after radiotherapy in oropharyngeal squamous cell carcinoma.
    Radiother Oncol. 2026;221:111620.
    PubMed         Abstract available
    
    
83. HSU C, Ku HL, Lin SM, Lee HL, et al
    Multicenter validation and randomized crossover reader evaluation of deep learning-assisted tri-sequence three-dimensional MRI segmentation for hypopharyngeal tumor.
    Radiother Oncol. 2026;221:111606.
    PubMed         Abstract available
    
    
84. HARALDSSON A, Askmyr D, Altunbulakli C, Nilsson M, et al
    Artificial intelligence classification of spatial CD8 + T-cell distribution on computed tomography in oropharyngeal cancer.
    Radiother Oncol. 2026;221:111607.
    PubMed         Abstract available
    
    
85. DE LEEUW ALMP, Giralt J, Tao Y, Hoebers FJP, et al
    Acute and long-term toxicity profiles and final oncologic outcomes in the phase III ARTFORCE trial.
    Radiother Oncol. 2026;221:111572.
    PubMed         Abstract available
    
    
86. TURCAS A, Williamson A, Gleim N, Kazda T, et al
    Neurocognition after brain irradiation: dose-volume effects and regional radiosensitivity - a systematic review by the ESTRO CNS focus group.
    Radiother Oncol. 2026;221:111574.
    PubMed         Abstract available
    
    
87. PENG Y, Chen S, Qin A, Chen M, et al
    Corrigendum to "Magnetic resonance-based synthetic computed tomography images generated using generative adversarial networks for nasopharyngeal carcinoma radiotherapy treatment planning" [Radiother. Oncol. 150 (2020) 217-224].
    Radiother Oncol. 2026;222:111609.
    PubMed        
    
    

    
    Surgery

88. TANG X, Li Q, Wang Y, Liu G, et al
    Perioperative outcomes of neoadjuvant immunochemoradiotherapy versus immunochemotherapy followed by surgery in elderly patients with locally advanced esophageal squamous cell carcinoma.
    Surgery. 2026;197:110379.
    PubMed         Abstract available
    
    

    
    Thyroid

89. CHEN W, Zheng Y, Mei P, Chen G, et al
    Comparison of Conventional Smears with Liquid Preparations and Their Combined Use in Thyroid Cytopathology: A Multi-Institutional Study.
    Thyroid. 2026 Jun 1:10507256261457010. doi: 10.1177/10507256261457010.
    PubMed         Abstract available
    
    
90. FERNANDEZ VELASCO P, Torres B, Estevez Asensio L, Cocho Cuesta A, et al
    Prospective Evaluation of Follow-Up De-Escalation to Primary Care in Differentiated Thyroid Cancer with Excellent Response to Therapy.
    Thyroid. 2026 May 25:10507256261454209. doi: 10.1177/10507256261454209.
    PubMed         Abstract available
    
    
91. JENSEN CB, Bacon EM, Xie S, Keshwani A, et al
    Fatigue after Thyroidectomy: A Qualitative Exploration of Patients' Lived Experiences.
    Thyroid. 2026 May 18:10507256261450430. doi: 10.1177/10507256261450430.
    PubMed         Abstract available
    
    
92. WATTS E, Sattar Z, Boelaert K, Sharma N, et al
    Risk Stratification Tools for Thyroid Cancer: A Systematic Review of Models Combining Ultrasound, Cytology, and Clinical Risk Factors.
    Thyroid. 2026 May 6:10507256261448300. doi: 10.1177/10507256261448300.
    PubMed         Abstract available
    
    
93. WILLEMS JIA, van Twist DJL, Pickwell KM, van Battum PLH, et al
    Diagnostic Yield of Thyroid Incidentaloma Evaluation and the Impact of Guideline Variability: Insights from a Retrospective Cohort Study.
    Thyroid. 2026 Apr 14:10507256261440405. doi: 10.1177/10507256261440405.
    PubMed         Abstract available
    
    
94. DEMIR AN, Sahin S, Gulhan D, Ozcelik AK, et al
    Sexual Function and Depressive Symptoms in Premenopausal Women with Differentiated Thyroid Cancer: A Cross-Sectional Study.
    Thyroid. 2026 Feb 27:10507256261427804. doi: 10.1177/10507256261427804.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Head and Neck Cancer is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum